Skip to main content Help with accessibility Skip to main navigation

AVATROMBOPAG tablets (Doptelet®▼) for chronic immune thrombocytopenia

CCG Approval Status:

Date Added: 25 - Mar - 2021
Grey

The Pan Mersey Area Prescribing Committee does not currently recommend the prescribing of AVATROMBOPAG tablets (Doptelet®▼) for chronic immune thrombocytopenia.